144 ·Filed Jun 24, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001950047-26-006447
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale following an option exercise — no material signal for the stock. Monitor for any acceleration of insider selling ahead of next earnings, but this single filing is not actionable.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
NTRA ▲ +41.67% at T+60d
NEUTRAL call ✓ call won +41.67% · α vs SPY +37.94% · entry $260.74 → $369.39
Entry anchored
Jun 24, 03:59 PM ET
via exchange tick
T+1d
+0.45%
call +0.45% · α +1.17%
$261.91
settled 3mo ago
T+5d
+5.96%
call +5.96% · α +4.40%
$276.27
settled 3mo ago
T+20d
+1.51%
call +1.51% · α +0.99%
$264.69
settled 2mo ago
T+60d
+41.67%
call +41.67% · α +37.94%
$369.39
settled 14d ago

Price Chart

Loading chart...

Executive Summary

Director Herman Rosenman filed a Form 144 notice of intent to sell 16,530 shares of Natera common stock, valued at approximately $4.13 million, following a stock option exercise. The sale represents a routine insider diversification event and is not unusual given the director's role and the company's large market cap.

Key Facts

  • Director Herman Rosenman filed Form 144 to sell 16,530 shares of NTRA common stock.
  • Estimated sale value is approximately $4.13 million based on filing date.
  • Shares were acquired via stock option exercise on June 24, 2026.
  • The sale is planned for the open market through Morgan Stanley Smith Barney LLC.
  • Rosenman's total beneficial ownership is 143,215,382 shares (including options).
  • The sale represents about 0.01% of shares outstanding, a negligible fraction.

Financial Impact

Sale of 16,530 shares valued at ~$4.13 million, representing ~0.01% of outstanding shares.

dilution

Risk Factors

  • Insider selling could accelerate if more Form 144s or Form 4s appear from other officers.
  • Option-exercise sales are common and not necessarily indicative of bearish sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
89% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006447
Document: 0001950047-26-006447-index.html0001950047-26-006447
Document: 0001950047-26-006447.txt0001950047-26-006447
35 reports for NTRA
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+1▲ +3.43%Feb 28, 2026
Filters
Rows
Reports for NTRA — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 3/10
$328.18 $341.79▲ +4.15%▲ +5.36%$402.75 (+22.72%)
Aug 29, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$321.96 $328.59▼ −2.06%▼ −2.20%$402.75 (−25.09%)
Aug 15, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$314.18 $327.72▲ +4.31%▲ +5.50%$402.75 (+28.19%)
Aug 8, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$318.35 $314.18▼ −1.31%▼ −1.26%$402.75 (+26.51%)
Aug 6, 2026
8w ago
Insider Cluster
BEARISH ★ 4/10
$265.38 $310.78▼ −17.11%▼ −15.89%$402.75 (−51.76%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$269.66 $265.38▼ −1.59%▼ −5.21%$402.75 (+49.35%)
Jul 18, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$262.63 $261.99▼ −0.24%▲ +0.18%$402.75 (+53.35%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$269.83 $264.69▼ −1.90%▼ −0.23%$402.75 (+49.26%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$281.85 $269.83▼ −4.26%▼ −4.13%$402.75 (+42.90%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$281.27 $272.66▼ −3.06%▼ −3.61%$402.75 (+43.19%)
Showing 10 of 35

US Market Status

Market Open — Closes in 1h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access